MEDINET GROUP (08161) plans to sell all issued shares of Heung Chuen for 14.4 million Hong Kong dollars.
The Yihe Group (08161) issued an announcement on January 9, 2025, that the seller (a wholly-owned subsidiary of the company) has entered into...
MEDINET GROUP (08161) announced that on January 9, 2025, the seller (a wholly-owned subsidiary of the company) entered into a purchase agreement with the buyer, Zhao Chuangbo. The seller conditionally agreed to sell, and the buyer conditionally agreed to acquire all the issued shares of the target company for HKD 14.4 million, subject to the terms and conditions of the purchase agreement.
Upon completion, the target company, Hengquan, will no longer be an indirect wholly-owned subsidiary of the company, and the financial performance of the target company will no longer be consolidated into the company's accounts.
The target company, Hengquan Limited, primarily operates dental clinics providing dental services, including teeth alignment treatment, laser dental implant surgery, teeth whitening, and other general dental services.
On July 12, 2018, the group acquired the target company from the buyer's controlled company, Tradewide Investments Limited. Since the acquisition, the target company's dental services business has faced significant challenges due to the impact of COVID-19. The group's dental industry has further been affected in the post-COVID era, especially with the reopening of borders leading to a influx of patients seeking dental treatment in Shenzhen. Changes in consumer behavior have negatively impacted the dental business in Hong Kong, resulting in continuous losses for the target company over the past year. The target company has incurred losses in the two fiscal years ending March 31, 2024. Therefore, the company believes that continuing to operate the dental clinics business is not feasible for the target company. The sale transaction will allow the group to realize the remaining value of the target company, reduce additional costs for providing dental services in Hong Kong, and supplement the group's cash resources to better utilize resources for developing the group's healthcare services business.
Related Articles

ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.
ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


